Font: Financial Modeling Prep • Aug 27, 2026
Royal Bank of Canada (NYSE: RY) is one of Canada's largest financial institutions, offering a wide range of banking and financial services. The bank recently announced strong financial results for its third quarter, continuing a trend of positive performance and exceeding market expectations for both its earnings and revenue.
On August 27, 2026, Royal Bank of Canada reported an earnings per share (EPS) of $3.07, surpassing the analyst estimate of $2.89. This represents a 6.23% surprise and an increase from the $2.79 per share reported a year ago. As highlighted by Zacks Investment Research, Royal Bank of Canada has now beaten EPS estimates for four straight quarters.
The company also announced revenue of $13.28 billion, which exceeded the estimated $12.98 billion. This figure is up from $12.36 billion in the same quarter last year. The strong performance contributed to a record third-quarter income of C$6.02 billion, as detailed in a report by WSJ.
Royal Bank of Canada's valuation can be viewed through its Price-to-Earnings (P/E) ratio of 18.29. This metric suggests what investors are willing to pay for each dollar of the company's earnings. Another key metric is the Price-to-Sales (P/S) ratio, which stands at 2.82 and compares the stock price to its revenues.
Royal Bank of Canada's financial health is reflected in its Debt-to-Equity ratio of 2.77. This ratio measures a company's debt against its shareholder equity, showing its financial leverage. Furthermore, Royal Bank of Canada's current ratio is 4.42, indicating a strong ability to cover its short-term obligations with its short-term assets.
|
VNRX§>
VolitionRX Ltd
|
$0.50
47.70%
|
|
NVDA§>
NVIDIA Corporation
|
$227.98
8.74%
|
|
RITR§>
Reitar Logtech Holdings Limited Ordinary shares
|
$0.10
11.75%
|
|
CELU§>
Celularity Inc.
|
$2.10
138.53%
|
|
NVD§>
GraniteShares 2x Short NVDA Daily ETF
|
$3.73
-16.93%
|
|
WKSP§>
Worksport Ltd.
|
$0.63
23.53%
|
|
MERC§>
Mercer International Inc.
|
$0.39
-5.57%
|
|
INTC§>
Intel Corp.
|
$92.09
4.36%
|
|
NCPL§>
Netcapital Inc.
|
$0.54
7.55%
|
|
PPCB§>
Propanc Biopharma, Inc.
|
$2.23
108.41%
|